SCHEDULE 13G: Sabby Management and Affiliates Disclose 9.9% Passive Stake in Universe Pharmaceuticals INC
Beneficial Ownership Disclosure
Sabby Management, LLC, Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz have jointly disclosed a 9.9% beneficial ownership stake in Universe Pharmaceuticals INC, held for passive investment purposes.
Summary
- Sabby Management, LLC, Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz collectively reported beneficial ownership of 727,190 Ordinary Shares of Universe Pharmaceuticals INC.
- This aggregate ownership represents 9.9% of the Ordinary Shares outstanding for Universe Pharmaceuticals INC.
- The filing, a Schedule 13G, indicates that the shares are held for investment purposes and not with the intent to change or influence the control of the issuer.
- The event requiring this filing occurred on December 31, 2024.
- All reporting persons share both voting and dispositive power over the 727,190 shares.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate positive or negative sentiment regarding the issuer's performance or outlook.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a significant passive investment by an institutional investor in a publicly traded company within the pharmaceutical sector. It does not provide specific insights into broader industry trends or competitive landscape beyond the ownership structure of Universe Pharmaceuticals INC.
Stakeholder Impact
- Shareholders: Disclosure of a significant passive stake by an institutional investor provides transparency regarding the ownership structure and may be viewed by the market as a vote of confidence or increased institutional interest in the company.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (beneficial ownership threshold reached). |
| 01/03/2025 | Date of signing and filing of the Schedule 13G statement. |
Keywords
Universe Pharmaceuticals INC, Sabby Management, Sabby Volatility Warrant Master Fund, Hal Mintz, Beneficial Ownership, Schedule 13G, Ordinary Shares, Investment Fund, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.